Intellia Therapeutics Aktie
8,00
EUR
-0,46
EUR
-5,39
%
9,12
USD
-0,08
USD
-0,87
%
Werbung
Intellia Therapeutics Aktie Analyse
15.05.18 | Intellia Therapeutics Buy | Chardan Capital Markets | |
28.03.17 | Intellia Therapeutics Buy | Chardan Capital Markets | |
31.05.16 | Intellia Therapeutics Outperform | Wedbush Morgan Securities Inc. |
Werbung
Werbung